10-Q Filing

ABBVIE INC. CIK: 1551152 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001551152-22-000017`
Period End Date	20220331
Filing Date	20220506
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	abbv-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 38 Cash Flow Statement 67 Stockholders Equity 20 Comprehensive Income 26

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Common stock, authorized (in shares)	`CommonStockSharesAuthorized`	4.00B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.10B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.80B	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.75B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	1.81B	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$1.47B	USD	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	44.56M	shares	Point-in-time
Common stock held in treasury, at cost (in shares)	`TreasuryStockShares`	34.86M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$84.00M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$9.98B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$10.73B	USD	Point-in-time
Inventories	`InventoryNet`	$3.48B	USD	Point-in-time
Inventories	`InventoryNet`	$3.13B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.99B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssets`	$4.72B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$26.51B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.93B	USD	Point-in-time
Investments	`LongTermInvestments`	$260.00M	USD	Point-in-time
Investments	`LongTermInvestments`	$277.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.11B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.08B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$75.95B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$73.99B	USD	Point-in-time
Goodwill	`Goodwill`	$32.30B	USD	Point-in-time
Goodwill	`Goodwill`	$32.38B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.08B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.88B	USD	Point-in-time
Total assets	`Assets`	$146.53B	USD	Point-in-time
Total assets	`Assets`	$143.21B	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$14.00M	USD	Point-in-time
Short-term borrowings	`ShortTermBorrowings`	$12.00M	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$12.48B	USD	Point-in-time
Current portion of long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$9.94B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.70B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.57B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.19B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$32.52B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$63.52B	USD	Point-in-time
Long-term debt and finance lease obligations	`LongTermDebtAndCapitalLeaseObligations`	$64.19B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.01B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.83B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$28.70B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$28.02B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,811,430,573 shares issued as of March 31, 2022 and 1,803,195,293 as of December 31, 2021	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,811,430,573 shares issued as of March 31, 2022 and 1,803,195,293 as of December 31, 2021	`CommonStockValueOutstanding`	$18.00M	USD	Point-in-time
Common stock held in treasury, at cost, 44,557,588 shares as of March 31, 2022 and 34,857,597 as of December 31, 2021	`TreasuryStockValue`	$4.58B	USD	Point-in-time
Common stock held in treasury, at cost, 44,557,588 shares as of March 31, 2022 and 34,857,597 as of December 31, 2021	`TreasuryStockValue`	$3.14B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.30B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$18.73B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.10B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.13B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.90B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.98B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.28B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.41B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$28.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$31.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$146.53B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$143.21B	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$13.01B	USD	1 Quarter
Net revenues	`Revenues`	$13.54B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.05B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$4.21B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.84B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.13B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.67B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.50B	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$185.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$145.00M	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$8.91B	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$8.82B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$4.72B	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$4.10B	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-539.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-622.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-9.00M	USD	1 Quarter
Net foreign exchange loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-25.00M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$776.00M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$395.00M	USD	1 Quarter
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.93B	USD	1 Quarter
Earnings before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.87B	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$436.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$312.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$3.56B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.49B	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.49B	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$3.55B	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$2.00	USD	1 Quarter
Basic earnings per share (in dollars per share)	`EarningsPerShareBasic`	$2.52	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$2.51	USD	1 Quarter
Diluted earnings per share (in dollars per share)	`EarningsPerShareDiluted`	$1.99	USD	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.77B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.77B	shares	1 Quarter
Weighted-average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.78B	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$3.56B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.49B	USD	1 Quarter
Depreciation	`Depreciation`	$198.00M	USD	1 Quarter
Depreciation	`Depreciation`	$206.00M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.85B	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.01B	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-28.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-194.00M	USD	1 Quarter
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-343.00M	USD	1 Quarter
Change in fair value of contingent consideration liabilities	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-748.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$306.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$269.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$185.00M	USD	1 Quarter
Acquired IPR&D and milestones	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$145.00M	USD	1 Quarter
Other, net	`OtherNoncashIncomeExpense`	$20.00M	USD	1 Quarter
Other, net	`OtherNoncashIncomeExpense`	$-128.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$785.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$866.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$187.00M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$385.00M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$330.00M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$285.00M	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$236.00M	USD	1 Quarter
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-258.00M	USD	1 Quarter
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$191.00M	USD	1 Quarter
Income tax assets and liabilities, net	`IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable`	$438.00M	USD	1 Quarter
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.91B	USD	1 Quarter
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.88B	USD	1 Quarter
Acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$198.00M	USD	1 Quarter
Acquisitions and investments	`PaymentsToAcquireOtherInvestments`	$185.00M	USD	1 Quarter
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$188.00M	USD	1 Quarter
Acquisitions of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$162.00M	USD	1 Quarter
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$1.41B	USD	1 Quarter
Purchases of investment securities	`PaymentsToAcquireMarketableSecurities`	$16.00M	USD	1 Quarter
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$8.00M	USD	1 Quarter
Sales and maturities of investment securities	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$11.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-154.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-49.00M	USD	1 Quarter
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-342.00M	USD	1 Quarter
Cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.59B	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.00B	USD	1 Quarter
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.88B	USD	1 Quarter
Repayments of long-term debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	-	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$2.53B	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$2.32B	USD	1 Quarter
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$787.00M	USD	1 Quarter
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.47B	USD	1 Quarter
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$128.00M	USD	1 Quarter
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$71.00M	USD	1 Quarter
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$132.00M	USD	1 Quarter
Payments of contingent consideration liabilities	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$246.00M	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-4.00M	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$21.00M	USD	1 Quarter
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.97B	USD	1 Quarter
Cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.17B	USD	1 Quarter
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-55.00M	USD	1 Quarter
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$7.00M	USD	1 Quarter
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.31B	USD	1 Quarter
Net change in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.65B	USD	1 Quarter
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.76B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.75B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.76B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.45B	USD	Point-in-time
Cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.75B	USD	Point-in-time

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$4.49B	USD	1 Quarter
Net earnings attributable to AbbVie Inc.	`NetIncomeLoss`	$3.55B	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-178.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-85.00M	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$2.32B	USD	1 Quarter
Dividends declared	`DividendsCommonStockCash`	$2.51B	USD	1 Quarter
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.47B	USD	1 Quarter
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$787.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$362.00M	USD	1 Quarter
Stock-based compensation plans and other	`StockIssuedDuringPeriodValueShareBasedCompensation`	$454.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Change in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.44B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.10B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.31B	USD	Point-in-time

Comprehensive Income 26 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$3.56B	USD	1 Quarter
Net earnings	`ProfitLoss`	$4.49B	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-7.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $(7) for the three months ended March 31, 2022 and $(25) for the three months ended March 31, 2021	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-677.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax expense (benefit) of $(7) for the three months ended March 31, 2022 and $(25) for the three months ended March 31, 2021	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-231.00M	USD	1 Quarter
Foreign currency translation adjustments, tax expense (benefit)	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-25.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $37 for the three months ended March 31, 2022 and $103 for the three months ended March 31, 2021	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$130.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$37.00M	USD	1 Quarter
Net investment hedging activities, net of tax expense (benefit) of $37 for the three months ended March 31, 2022 and $103 for the three months ended March 31, 2021	`OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax`	$374.00M	USD	1 Quarter
Net investment hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossNetInvestmentHedgeTax`	$103.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $10 for the three months ended March 31, 2022 and $19 for the three months ended March 31, 2021	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-28.00M	USD	1 Quarter
Pension and post-employment benefits, net of tax expense (benefit) of $10 for the three months ended March 31, 2022 and $19 for the three months ended March 31, 2021	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-79.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-10.00M	USD	1 Quarter
Pension and post-employment benefits, tax expense (benefit)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax`	$-19.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(2) for the three months ended March 31, 2022 and $3 for the three months ended March 31, 2021	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$46.00M	USD	1 Quarter
Cash flow hedging activities, net of tax expense (benefit) of $(2) for the three months ended March 31, 2022 and $3 for the three months ended March 31, 2021	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-12.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$3.00M	USD	1 Quarter
Cash flow hedging activities, tax expense (benefit)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	$-2.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-178.00M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-85.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.38B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.41B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$3.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$2.00M	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$3.38B	USD	1 Quarter
Comprehensive income attributable to AbbVie Inc.	`ComprehensiveIncomeNetOfTax`	$4.41B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.